» Articles » PMID: 7603722

Acoustic Neuroma (vestibular Schwannoma): Growth and Surgical and Nonsurgical Consequences of the Wait-and-see Policy

Overview
Publisher Wiley
Date 1995 Jul 1
PMID 7603722
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

A prospective study of the consequences of the wait-and-see policy in in patients with neuroradiologic diagnostic evidence of having vestibular schwannoma was conducted in a series of 123 patients (127 tumors) over a 20-year period, from 1973 to 1993. The mean follow-up period was 3.4 years, mean annual growth rate was 3.2 mm/year, mean annual volume growth rate was 0.72 ml/year, and mean annual relative growth rate was 41%. Tumor growth was observed in 90 (74%) patients (94 tumors), no growth was seen in 23 (18%) patients (23 tumors), and negative tumor growth was seen in 10 (8%) patients (10 tumors). Surgery due to tumor growth was performed in 35 (28%) patients (35 tumors), 7 (6%) patients (7 tumors) were treated with gamma-radiation and/or shunt insertion, 7 (6%) patients died of brain stem herniation induced by tumor compression, 9 (7%) patients died of non-tumor-related causes, 28 patients were classified as candidates for hearing preservation surgery, and 21 (75%) patients lost their candidacy during the observation period due to tumor growth and/or deterioration of hearing. The results may limit indications for allocation of patients with vestibular schwannoma to the wait-and-see group.

Citing Articles

Outcomes of Extended Middle Fossa Approach for Petroclival Tumors in the Elderly.

Kaul V, Harris M, Kato M, Finger G, Gao T, Hardesty D J Neurol Surg B Skull Base. 2024; 85(Suppl 2):e110-e116.

PMID: 39444776 PMC: 11495911. DOI: 10.1055/a-2219-2551.


Bevacizumab Treatment for Patients with -Related Schwannomatosis: A Single Center Experience.

Douwes J, Hensen E, Jansen J, Gelderblom H, Schopman J Cancers (Basel). 2024; 16(8).

PMID: 38672561 PMC: 11047890. DOI: 10.3390/cancers16081479.


Evaluating growth trends of residual sporadic vestibular schwannomas: a systematic review and meta-analysis.

Egiz A, Nautiyal H, Alalade A, Gurusinghe N, Roberts G J Neurooncol. 2022; 159(1):135-150.

PMID: 35761159 DOI: 10.1007/s11060-022-04051-2.


Understanding the Molecular Mechanism of Vestibular Schwannoma for Hearing Preservation Surgery: Otologists' Perspective from Bedside to Bench.

Hosoya M, Wakabayashi T, Wasano K, Nishiyama T, Tsuzuki N, Oishi N Diagnostics (Basel). 2022; 12(5).

PMID: 35626200 PMC: 9140016. DOI: 10.3390/diagnostics12051044.


Sporadic Vestibular Schwannoma Size and Location Do not Correlate With the Severity of Hearing Loss at Initial Presentation.

Brown A, Early S, Vasilijic S, Stankovic K Front Oncol. 2022; 12:836504.

PMID: 35372070 PMC: 8965062. DOI: 10.3389/fonc.2022.836504.